drug · antibody drug conjugate
patient view →trastuzumab emtansine
Marketedupdated 2mo agoby Genentech Inc🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug conjugate drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 4 investigational indications.
targets
Receptor tyrosine-protein kinase erbB-2Tubulin
all catalysts(14)
approval · 14
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that